Professional Experience
Over her career, Dr. Brems-Eskildsen has held multiple clinical and research positions, enhancing her expertise in oncology and patient care.
- Current Position: Senior Consultant, MD, PhD, Department of Oncology, Aarhus University Hospital
- Previous Roles:
- Medical Doctor, Department of Pathology, Aarhus University, 2012–2013
- Medical Doctor, Department of Oncology, Aarhus University Hospital, 2013–2014
- PhD Student, Department of Molecular Medicine (MOMA), Aarhus University Hospital, 2005–2010
Academic Contributions
Dr. Brems-Eskildsen actively contributes to oncology research and education, mentoring students and sharing her expertise with colleagues worldwide.
- Research Interests: Breast cancer pharmacology, metastatic breast cancer, vinorelbine treatment
- Teaching & Mentorship: Conducts research training, mentorship programs, and lectures within the Department of Oncology
- Research Output: Authored multiple peer-reviewed publications in leading oncology journals
Areas of Expertise
Her clinical practice focuses on advanced breast cancer care, providing both cutting-edge treatments and patient-centered support.
- Conditions Treated: Metastatic breast cancer, advanced breast cancer
- Procedures & Treatments: Chemotherapy regimens, pharmacological interventions, and comprehensive patient management in advanced cancer stages
Publications and Research
Dr. Brems-Eskildsen has published extensively in oncology, contributing to the understanding and treatment of metastatic breast cancer.
- 2025: “A direct comparison of classical oral Navelbine vs. metronomic Navelbine in metastatic breast cancer” – Study evaluating the efficacy and safety of two chemotherapy agents in metastatic breast cancer patients. PubMed
- 2024: “375P Results from the Danish Breast Cancer Group’s study” – Research findings on breast cancer treatment outcomes. Annals of Oncology
- 2021: “Metronomic treatment of vinorelbine with oral capecitabine in metastatic breast cancer” – Investigating alternative chemotherapy combinations for metastatic breast cancer patients. Acta Oncologica
Patient Care Philosophy
Dr. Brems-Eskildsen emphasizes personalized, compassionate care. She prioritizes clear communication, patient education, and a collaborative approach to treatment planning. Her practice includes support for international patients and culturally sensitive care tailored to individual needs.
- Patient Communication: Ensures patients understand their diagnosis, treatment options, and expected outcomes
- Empathy: Prioritizes patient comfort and emotional support throughout treatment
- International Patients: Offers consultations and treatment planning for patients from outside Denmark
Professional Affiliations
Dr. Brems-Eskildsen is actively involved in several professional organizations that enhance her clinical practice and research contributions. These affiliations allow her to stay updated on the latest advancements in oncology, collaborate with international experts, and contribute to the development of new treatment guidelines. Her participation in both national and international networks reflects her commitment to improving patient care and advancing the field of oncology.
- National: Member of the Danish Society for Oncology, contributing to national cancer care standards and policy development
- International: Active participant in European and global oncology research networks, collaborating on multicenter studies and clinical trials
- Leadership Roles: Involved in committees and working groups focused on breast cancer research and treatment protocols
- Certifications: Board-certified in Medical Oncology, Denmark, ensuring compliance with national and international standards of clinical excellence
FAQs
- Is Dr. Anne Sofie Brems-Eskildsen board-certified?
- Yes, she is board-certified in Medical Oncology in Denmark.
- What types of surgeries does she perform?
- Dr. Brems-Eskildsen specializes in medical oncology and does not perform surgical procedures.
- Does she treat international patients?
- Yes, she offers consultations and treatment planning for international patients.
- How long is the typical hospital stay?
- The duration varies depending on the treatment plan and patient response; Dr. Brems-Eskildsen provides individualized care to determine the appropriate length of stay.
- What languages does she speak?
- Dr. Brems-Eskildsen is fluent in Danish and English, facilitating communication with a broad range of patients.
- What is her approach to advanced breast cancer treatment?
- She uses evidence-based pharmacological treatments, personalized care plans, and supportive management to optimize patient outcomes.
- Does she participate in clinical research?
- Yes, she actively conducts and publishes research focused on metastatic breast cancer treatment and chemotherapy optimization.
